Acta Vet. Brno 2011, 80: 391-396

https://doi.org/10.2754/avb201180040391

Effects of amlodipine on bone metabolism in male albino Wistar rats

Iveta Gradošová1, Helena Živná2, Klára Švejkovská1, Vladimír Palička1, Aleš Tichý3, Pavel Živný1

1Institute of Clinical Biochemistry and Diagnostics, Medical Faculty and University Hospital, Hradec Králové, Czech Republic
2Radioisotope Laboratories and Vivarium, Faculty of Medicine in Hradec Králové, Charles University in Prague, Czech Republic
3Department of Radiobiology, University of Defence, Faculty of Military Health Sciences, Hradec Králové, Czech Republic

References

1. Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, Dooley KC, Don-Wauchope A, Douville P, Hanley DA, Jamal SA, Josse R, Kaiser S, Krahn J, Krause R, Kremer R, Lepage R, Letendre E, Morin S, Ooi DS, Papaioaonnou A, Ste-Marie LG 2009: Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 42: 929-942 <https://doi.org/10.1016/j.clinbiochem.2009.04.001>
2. Devabhaktuni M, Bangalore S: Fixed combination of amlodipine and atorvastatin in cardiovascular risk management 2009: patient perspectives. Vasc Health Risk Manag 5: 377-387
3. Duncan RL, Akanbi KA, Farach-Carson MC 1998: Calcium signals and calcium channels in osteoblastic cells. Semin Nephrol 18: 178-190
4. Gradosova I, Zivna A, Svejkovska K, Palicka V, Tichy A, Zivny P 2011: The role of atorvastatin in bone metabolism in male albino Wistar rats. Pharmazie 66: 606-610
5. Gu Y, Preston MR, Magnay J, El Haj AJ, Publicover SJ 2001: Hormonally-regulated expression of voltage-operated Ca(2+) channels in osteocytic (MLO-Y4) cells. Biochem Biophys Res Commun 282: 536-542 <https://doi.org/10.1006/bbrc.2001.4615>
6. Halici Z, Borekci B, Ozdemir Y, Cadirci E, Suleyman H 2008: Protective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats. Eur J Pharmacol 579: 241-245 <https://doi.org/10.1016/j.ejphar.2007.09.027>
7. Herrmann M, Seibel MJ 2008: The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta 393: 57-75 <https://doi.org/10.1016/j.cca.2008.03.020>
8. Katagiri T, Takahashi N 2002: Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8: 147-159 <https://doi.org/10.1034/j.1601-0825.2002.01829.x>
9. Kurihara N, Ishizuka S, Kiyoki M, Haketa Y, Ikeda K, Kumegawa M 1986: Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology 118: 940-947 <https://doi.org/10.1210/endo-118-3-940>
10. Lieberherr M 1987: Effects of vitamin D3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J Biol Chem 262: 13168-13173
11. Morain P, Peglion JL, Giesen-Crouse E 1992: Ca2+ channel inhibition in a rat osteoblast-like cell line, UMR 106, by a new dihydropyridine derivative, S11568. Eur J Pharmacol 220: 11-17 <https://doi.org/10.1016/0014-2999(92)90005-O>
12. Nakatani Y, Tsunoi M, Hakeda Y, Kurihara N, Fujita K, Kumegawa M 1984: Effects of parathyroid hormone on cAMP production and alkaline phosphatase activity in osteoblastic clone MC3T3-E1 cells. Biochem Biophys Res Commun 123: 894-898 <https://doi.org/10.1016/S0006-291X(84)80219-3>
13. Nishiya Y, Sugimoto S 2001: Effects of various antihypertensive drugs on the function of osteoblast. Biol Pharm Bull 24: 628-633 <https://doi.org/10.1248/bpb.24.628>
14. Rejnmark L, Vestergaard P, Mosekilde L 2006: Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24: 581-589 <https://doi.org/10.1097/01.hjh.0000203845.26690.cb>
15. Ritchie CK, Maercklein PB, Fitzpatrick LA 1994: Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations. Endokrinology 135: 996-1003 <https://doi.org/10.1210/en.135.3.996>
16. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R 2008: Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22: 2465-2475 <https://doi.org/10.1096/fj.07-098954>
17. Ushijima K, Liu Y, Maekawa T, Ishikawa E, Motosugi Y, Ando H, Tsuruoka S, Fujimura A 2010: Protective effect of amlodipine against osteoporosis in stroke-prone spontaneously hypertensive rats. Eur J Pharmacol 635: 227-230 <https://doi.org/10.1016/j.ejphar.2010.02.039>
18. Zahanich I, Graf EM, Heubach JF, Hempel U, Boxberger S, Ravens U 2005: Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 20: 1637-164 <https://doi.org/10.1359/JBMR.050521>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Indexed in DOAJ

Archive